• Estradiol Inhibits ER Stress to Restore CD4+ T Cells After H

  2026-06-17

  This study demonstrates that 17β-estradiol (E2) restores impaired splenic CD4+ T lymphocyte function after hemorrhagic shock by inhibiting endoplasmic reticulum (ER) stress. The findings clarify estrogen receptor subtype involvement and highlight ER stress as a mechanistic link between trauma and immune suppression, offering new avenues for immunomodulatory research.

• Guanabenz Acetate: New Frontiers in α2-Adrenergic and Immune

  2026-06-17

  Explore how Guanabenz Acetate, a selective α2-adrenergic receptor agonist, advances both GPCR signaling and innate immunity research. This article uniquely bridges molecular pharmacology and viral immunology, offering distinct insights for neuroscience and antiviral assay design.

• 5-(N,N-dimethyl)-Amiloride Hydrochloride: Unraveling Ion Tra

  2026-06-16

  Explore how 5-(N,N-dimethyl)-Amiloride hydrochloride advances research into Na+/H+ exchanger signaling, intracellular pH regulation, and endothelial protection in sepsis models. This article offers a unique experimental perspective, connecting mechanistic insights with practical assay optimization.

• EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1

  2026-06-16

  EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent designed for efficient amide bond formation in peptide synthesis, bioconjugation, and nucleotide synthesis workflows. It is intended exclusively for in vitro laboratory applications and should not be used in in vivo or clinical contexts due to the absence of supporting data.

• HRP Goat Anti-Mouse IgG (H+L) Antibody: Protocol & QC Guide

  2026-06-15

  The HRP Goat Anti-Mouse IgG (H+L) Antibody addresses the need for robust, high-specificity detection of mouse primary antibodies in immunoassays such as Western blot, ELISA, IHC, and ICC. This reagent is best suited for workflows requiring horseradish peroxidase-based signal amplification. It is not recommended for detection of non-mouse primaries or for applications involving direct detection of antigens without a mouse IgG primary antibody.

• Shionone Activates PINK1-Parkin Mitophagy to Alleviate Pulmo

  2026-06-15

  This study reveals that shionone, a terpenoid from Ligularia fischeri, mitigates pulmonary fibrosis by activating PINK1-Parkin-dependent mitophagy in alveolar epithelial cells. The findings not only clarify shionone’s anti-fibrotic mechanism but also highlight targeted mitophagy as a promising therapeutic avenue for progressive lung disease.

• BMS-777607 in MET Pathway Inhibition: Advanced Protocols & I

  2026-06-14

  Explore the scientific depth behind BMS-777607 as a selective c-Met inhibitor, revealing its unparalleled role in MET signaling pathway inhibition and advanced applications in cancer and platelet research. This article uniquely bridges mechanistic detail with practical assay decisions.

• Small-Molecule uPAR Inhibition Reduces Breast Cancer Metasta

  2026-06-13

  The reference study identifies and characterizes IPR-803, a competitive urokinase receptor inhibitor, as a potent disruptor of the uPAR–uPA protein–protein interaction central to tumor invasion. Comprehensive biochemical, cellular, and in vivo analyses demonstrate its efficacy in blocking breast cancer metastasis, providing a molecular template for future metastasis inhibitor development.

• Monomethyl auristatin E (MMAE): Precision Antimitotic Payloa

  2026-06-12

  Monomethyl auristatin E (MMAE) is a highly potent antimitotic agent used as a cytotoxic payload in antibody-drug conjugates (ADCs) for targeted cancer therapy. Its efficacy is supported by sub-nanomolar IC50 values in cancer cell lines and robust tumor regression in xenograft models. MMAE's solubility and storage properties make it a practical choice for precision oncology workflows.

• IPR-803: Mechanistic Insights and Translational Impact in uP

  2026-06-12

  Explore IPR-803 as a next-generation urokinase receptor inhibitor with mechanistic detail and translational context. This article uniquely dissects uPAR-uPA inhibition in breast and pancreatic cancer research, offering assay guidance and insight beyond standard protocols.

• Puromycin Aminonucleoside: Benchmarking Podocyte Injury Mode

  2026-06-11

  Puromycin aminonucleoside is the gold-standard tool for inducing podocyte injury and modeling nephrotic syndrome in vivo and in vitro. This guide outlines advanced workflows, troubleshooting strategies, and the latest solubility-based innovations, equipping renal researchers with the most robust approaches for reproducible glomerular lesion studies.

• BAPTA-AM: Precision Calcium Modulation for Translational Car

  2026-06-11

  Explore how BAPTA-AM, a cell-permeable calcium chelator, is transforming translational research into myocardial ischemia/reperfusion injury. This authoritative thought-leadership article bridges mechanistic insight with practical guidance—highlighting BAPTA-AM’s unique role in dissecting PANoptosis, optimizing apoptosis assays, and advancing neuroprotective and cardioprotective strategies. Drawing on the latest evidence, including cutting-edge Piezo1 research and expert workflow recommendations, this piece clarifies how to harness APExBIO’s BAPTA-AM for next-generation experimental design.

• Single-Cell Insights Into Ciprofloxacin–Tetracycline Antagon

  2026-06-10

  This study elucidates the antagonistic interaction between ciprofloxacin hydrochloride, a fluoroquinolone antibiotic, and tetracycline at the single-cell level, revealing that increased survival under drug combination is linked to nutrient environments and heterogeneity in DNA damage responses. The findings highlight the importance of quantifying bacterial responses at single-cell resolution to guide antibiotic combination strategies and anticipate resistance dynamics.

• Parathyroid Hormone (1-34) (Human): Precision Tools for Bone

  2026-06-10

  Explore the unique scientific and translational value of Parathyroid hormone (1-34) (human) as a powerful tool for dissecting bone metabolism and valvular calcification mechanisms. This article goes beyond established content, offering actionable insights for advanced experimental design.

• Tunicamycin: Precision N-Glycosylation Inhibitor for ER Stre

  2026-06-09

  Tunicamycin from APExBIO empowers researchers to dissect ER stress and inflammation mechanisms with reproducibility and specificity. Its validated role as an N-glycosylation inhibitor enables robust workflows for both in vitro and in vivo studies, while advanced troubleshooting ensures optimal results in demanding applications.

11369 records 1/758 page Next 12345 下5页 Last page